www.Top100Medicine.com - TOP 100 MEDICAL SITES
TOP 100 MEDICAL SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Webmaster 
Updated Sat, February 4, 2012.
751.www.atrovent.com78
752.www.annuaire-medecine-esthetique.com68
753.csd23.blogspot.com66
754.www.umc-utrecht.nl57
755.www.depo-medrol.com47
756.www.pictureshop.blogspot.com31
757.www.misa.us14
758.cicil.ukl.uni-freiburg.de9
759.www.docsplanet.com9
760.www.luigigrosso.net9
761.www.telemedicine24-7.com8
762.www.niaclin.com8
763.ameditic.blogspot.com8
764.myrenovate.com7
765.journaldunpharmacien.hostse.com7
766.www.easylapband.com6
767.www.praxis-sievering.com5
768.videosdemedecine.blogspot.com5
769.www.fropus.com4
770.www.healthorlando.com2
771.www.field-home-test.info2
772.www.amgpa.org2
773.www.thenaturalheal.com1
Pages:  1  2  3  4  5  6  7  8  9  10  11  12 
 13  14  15  16 



Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Newsvine

760. www.luigigrosso.net

Rating: 9 points*
*amount mentions of word 'www.luigigrosso.net' on the other websites

www.luigigrosso.net

Dr. Luigi Grosso

Description: Il sito web è al servizio di tutti in forma totalmente gratuita (INFO HONCODE).

Google

© 2005-2012 www.Top100Medicine.com
Astellas Buyout of OSI Pharmaceuticals Gets More Likely
Derek Lowe submits: So Astellas (ALPMY.PK) and OSI (OSIP) have finally come to terms. OSI's stock was at about $37 back in early March, and now the acquisition will go off at $57.50/share. That's an increase from the earlier $52 per share that Astellas offered, and comes after a month or two of wrangling - and, one would assume, attempts by OSI to see if another buyer might materialize. And we still don't know about that part, actually. From the Wall Street Journal: Astellas said in a statement the revised offer price is based on its review of OSI's non-public information since late April and its consideration of the US company's medium- and long-term corporate value. After extending its tender offer on April 23, Astellas has been reviewing OSI's confidential information on the condition that it wouldn't attempt to buy any OSI shares through May 15. Astellas President Masafumi Nogimori said in a news conference the newly offered price is "very reasonable," but he declined to comment on whether there were rival bids his company had to beat.Complete Story »
seekingalpha.com
ALS Research: CVS/pharmacy Campaign - Video
Two young fathers from Overland Park, Kansas and Pine Mountain Valley, Georgia are ALS patients serving as honorary co-chairs of campaign
feedproxy.google.com
Omnicare Profit Falls 60%
Omnicare, whose CEO abruptly retired last weekend, reported a steep drop in second-quarter profit due to a slowdown in the volume of drug prescriptions it fills for nursing homes and other clients.
online.wsj.com
FDA Rejects Roche Drug Review
Roche said the U.S. drug regulator rejected a priority review for a novel breast cancer drug, dashing hopes the treatment might be approved quickly.
online.wsj.com
Genoptix, Inc. to Announce Third Quarter 2010 Financial Results
[PR Newswire] - Genoptix, Inc. , a specialized laboratory services provider, announced today that it expects to report its financial results for the third quarter 2010 after closing of the NASDAQ Global Select Market on Thursday, November 4, 2010.
us.rd.yahoo.com